Search Results

Vaccine approaches for antigen capture by liposomes.

• Authors : Zhou, Shiqi; Luo, Yuan; Lovell, Jonathan F.

Subjects: LIPOSOMES; ANTIGENS; VACCINE effectiveness

• Source: Expert Review of Vaccines; 2023, Vol. 22 Issue 1, p1022-1040, 19p

Record details

Fueling Cancer Vaccines to Improve T Cell-Mediated Antitumor Immunity.

• Authors : Hernandez, Rosmely; Malek, Thomas R.

Subjects: CANCER vaccines; CELLULAR immunity; ANTIGENS

• Source: Frontiers in Oncology; 5/16/2022, Vol. 12, p1-15, 15p

Record details

Patent Application Titled "Self-Sustained Release Immune Adjuvant Suspension, Preparation Method Therefor, And Use Thereof" Published Online (USPTO 20240050560).

Subjects: IMMUNOLOGICAL adjuvants; PATENT applications; INTERNET publishing

• Source: Immunotherapy Weekly; 2024, p2221-2221, 1p

Record details

IFN-γ Licensing Does Not Enhance the Reduced Immunomodulatory Potential and Migratory Ability of Differentiation-Induced Porcine Bone Marrow-Derived Mesenchymal Stem Cells in an In Vitro Xenogeneic Application.

• Authors : Lee, Hyeon-Jeong; Kim, Hwan-Deuk; Jo, Chan-Hee

Subjects: CELL differentiation; IN vitro studies; MONONUCLEAR leukocytes

• Source: BioMed Research International; 9/6/2021, p1-15, 15p

Record details

Astragalus Polysaccharides Enhance the Immune Response to OVA Antigen in BALB/c Mice.

• Authors : Zhou, Yumei; Zong, Yuhan; Liu, Zihao

Subjects: POLYSACCHARIDES; ALBUMINS; HERBAL medicine

• Source: BioMed Research International; 6/29/2021, p1-6, 6p

Record details

Protein-based antigen presentation platforms for nanoparticle vaccines.

• Authors : Nguyen, Brian; Tolia, Niraj H.

Subjects: VACCINE effectiveness; IMMUNOLOGICAL adjuvants; NANOPARTICLE synthesis

• Source: NPJ Vaccines; 5/13/2021, Vol. 6 Issue 1, p1-11, 11p

Record details

Patient Preferences for Time and Location of Infusible Therapies in Multiple Sclerosis and Neuroimmunologic Disorders.

• Authors : Rath, Louise; Campagna, Maria Pia; Stankovich, Jim

Subjects: DISEASE relapse; MULTIPLE sclerosis treatment; RITUXIMAB

• Source: International Journal of MS Care; May/Jun2021, Vol. 23 Issue 3, p114-118, 5p

Record details

A Chimera of Th1 Stimulatory Proteins of Leishmania donovani Offers Moderate Immunotherapeutic Efficacy with a Th1-Inclined Immune Response against Visceral Leishmaniasis.

• Authors : Ratnapriya, Sneha; Keerti; Yadav, Narendra Kumar

Subjects: PROTEINS; HAMSTERS; LEISHMANIASIS

• Source: BioMed Research International; 2/27/2021, p1-14, 14p

Record details

Patent Issued for Cell-associating immunologic adjuvants for treatment enhancement (USPTO 11813326).

Subjects: IMMUNOLOGICAL adjuvants; THERAPEUTICS; LIGAND bindingTAIPEI (Taiwan)

• Source: Cancer Vaccine Week; 12/4/2023, p138-138, 1p

Record details

Editorial: Vaccines and Immunostimulants for Finfish.

• Authors : Munang'andu, Hetron M.; Salinas, Irene; Tafalla, Carolina

Subjects: VIBRIO anguillarum; IMMUNOLOGICAL adjuvants; VACCINES

• Source: Frontiers in Immunology; 9/29/2020, Vol. 11, pN.PAG-N.PAG, 4p

Record details